Skip to content

Biomarkers and the AD continuum

Professor Henrik Zetterberg, Sweden

Alzheimer's disease hub

Research and DiagnosticsBiomarkers

 

Biomarkers and the AD continuum

 

Professor Henrik Zetterberg, Sweden

September 30, 2022

 


 

"Alzheimer’s is a disease process that starts much earlier than we thought”

In just ten years, biomarkers have substantially improved our understanding and the way we diagnose Alzheimer’s disease.

Watch what else Professor Henrik Zetterberg has to say on the use of biomarkers & Alzheimer's Disease.

 

 

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

Leave Site

You are Leaving the Global Medically Site

By following this link, you are being redirected to another Roche page.